
Reduced glymphatic flow and facial allodynia induced by CGRP and mTBI are treated by an α1-noradrenergic receptor antagonist
&
Serine Hydrolase inhibitor AKU-005 to enhance endocannabinoids for treatment of migraine
Adriana Della Pietra, PhD
Postdoctoral Researcher
University of Iowa